
Nucs AI, the cutting-edge solution revolutionizing the clinical management of prostate cancer. Our platform harnesses the power of artificial intelligence to offer unparalleled insights into tumor lesions, empowering both patients and healthcare professionals with advanced analyses and evidence-based decision-making tools. With Nucs AI, patients with prostate cancer can navigate their treatment journey with confidence, knowing they have access to the most comprehensive and personalized information available. Our platform provides detailed assessments of tumor lesions, enabling healthcare professionals to tailor treatment plans to each individual's unique needs. By combining state-of-the-art AI technology with a commitment to patient care, Nucs AI is leading the way in transforming prostate cancer management. Join us in shaping the future of healthcare and improving outcomes for patients worldwide.

Nucs AI, the cutting-edge solution revolutionizing the clinical management of prostate cancer. Our platform harnesses the power of artificial intelligence to offer unparalleled insights into tumor lesions, empowering both patients and healthcare professionals with advanced analyses and evidence-based decision-making tools. With Nucs AI, patients with prostate cancer can navigate their treatment journey with confidence, knowing they have access to the most comprehensive and personalized information available. Our platform provides detailed assessments of tumor lesions, enabling healthcare professionals to tailor treatment plans to each individual's unique needs. By combining state-of-the-art AI technology with a commitment to patient care, Nucs AI is leading the way in transforming prostate cancer management. Join us in shaping the future of healthcare and improving outcomes for patients worldwide.
Focus: AI-driven analysis and reporting for PSMA-PET/CT to support prostate cancer care
Flagship products: DeepPSMA and SelectPSMA
Headquarters: San Francisco
Founders: Nijat Ahmadov (CEO) and Farid Yagubbayli (CTO)
Recent funding: $3.5M seed round
Prostate cancer imaging interpretation and treatment-response prediction (PSMA-PET/CT).
2024
Hospitals and Health Care
$3.5M
Company announcement of seed round; investor names not listed on announcement
| Company |
|---|
About Nucs AI Nucs AI is revolutionizing prostate cancer care through cutting-edge AI and medical imaging technology. Founded in 2024 by a multidisciplinary team of oncologists, AI researchers, and healthcare innovators, we're tackling one of medicine's most pressing challenges: the growing demand for accurate, timely cancer diagnostics in the face of rising scan volumes and limited radiologist capacity.
Our mission is to enhance diagnostic precision and expand access to expert-level prostate cancer screening, ultimately improving patient outcomes worldwide.
The Opportunity Join our engineering team as a Full Stack Engineer and help build the next generation of medical imaging platforms. You'll work at the intersection of healthcare and technology, developing secure, scalable systems that directly impact patient care and clinical workflows.
You'll design and implement robust distributed systems that power our AI diagnostic tools—architecting services that handle sensitive medical data reliably, scale gracefully under load, and integrate seamlessly with hospital infrastructure.
What You'll Build
What You Bring
Bonus Points
Why This Role Matters Your work will directly contribute to advancing cancer care technology. Every system you build, every optimization you make, and every integration you design helps medical professionals provide better care to patients facing one of life's most challenging diagnoses.
Interview Process Phone Screening (10 minutes)
Technical Interview
Cultural Interview